SAN FRANCISCO and PALO ALTO, Calif., Sept. 12 /PRNewswire/ -- Anacor Pharmaceuticals, a privately held pharmaceutical company, today announced it will make two presentations at the American Chemical Society National Meeting & Exposition this week in San Francisco. Researchers will make an oral presentation on the chemistry and discovery of AN2690, Anacor's topical antifungal drug candidate being developed for onychomycosis, a fungal infection of the toenail and nail bed, as well as a poster presentation on the discovery of AN0128, Anacor's treatment for atopic dermatitis.
